LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
Within 1 day
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Serum or plasma
Red-top tube or green-top (heparin) tube. Do not use a gel-barrier tube. The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending on the specimen volume and storage time, the decrease in drug level due to absorption may be clinically significant.
Transfer separated serum or plasma to a plastic transport tube. Trough: immediately prior to next dose; after change in dose: children: two days, adults: one to two days.
Gel-barrier tube; hemolysis; gross lipemia; icteric specimen
Therapeutic: neonatal: 5.0−10.0 μg/mL, adults: 10.0−20.0 μg/mL
Theophylline is prescribed for bronchial asthma, for chronic obstructive pulmonary disease, and for newborn apnea. The drug is extensively metabolized1 with peak serum levels reached four hours after oral dose. Troleandomycin and erythromycin may slow theophylline elimination. Heart failure, liver disease, prolonged fever, certain infections, and obesity may have similar effects. Prolonged half-life occurs in premature infants. Dosage should be reduced in these situations.
By contrast, half-life is shortened in smokers, variable with phenobarbital administration; higher doses are also tolerated in acidemia. Smokers on the average are reported to need 1.5 to 2 times as much of the drug as nonsmokers to achieve the same effects. Optimal resampling time after change in dosage is 48 hours for adults, one to two days for children. The half-life of theophylline is from 3 to 10 hours for adults and 1.4 to 7.9 hours for children, but varies between individuals.
Studying serum concentrations and toxic effects, Bertino et al found toxicity with peak theophylline concentrations as low as 19.4 mg/L. Recognizing theophylline toxicity over a wide range of theophylline levels, these authors questioned the association between the severity of toxic effects and serum concentrations.2 Aitken and Martin also found lack of correlation between serum theophylline level and toxic effects.3
Blood levels should be interpreted in light of the patient's clinical status and use of other medications.
Toxic effects include nausea, vomiting, diarrhea, headache, atrial and ventricular arrhythmias, tremors, and convulsions.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|007336||Theophylline, Serum||4049-3||007338||Theophylline, Serum||ug/mL||4049-3|
© 2019 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
The LOINC® codes are copyright © 1994-2018, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf